Clinicians 101: How can European ATMP manufacturers work with clinicians to safeguard patient access in a healthcare setting?
Joined Plenary – Navigating the path to commercialisation of ATMPs in Europe: funding, patient access and pricing and reimbursement
- Where is the greatest clinical need for ATMPs?
- How will ATMPs work in a healthcare setting? Are specific centres of excellence the answer to getting these therapies to patients successfully?
- Can industry collaborate with clinicians to ensure products are easier to administer? How can ATMP manufacturers further simplify the handling of CGT products in the clinic?
- How do clinicians view hospital exemption for ATMPs?
- 10 minute open floor discussion (to be carried on in the workshop following this session): clinicians and manufacturers to collaborate on how to gain wider patient access. What do manufacturers need from the clinicians and vice versa.